ArticleNucleic acid therapeutics2019

Optimization of a 40-mer Antimyelin DNA Aptamer Identifies a 20-mer with Enhanced Properties for Potential Multiple Sclerosis Therapy.

Brandon Wilbanks et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.